KBC Private Partners Life Sciences (PRIVAK)(SComm)

BE 0769.268.990

Follow-up
Company information
Status
Active
Enterprise number
BE0769.268.990
VAT liability
No
Established
02-06-2021
Last balance sheet year
2023
Company size
Medium-sized 0 FTE
Principal activity
Activities of trust, estate and agency accounts
Health barometer
Barometer background
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from KBC Private Partners Life Sciences (PRIVAK)

20232022
Profit/Loss
€ -16.12128%€ -22.372
Equity
€ 13.986.50867%€ 8.392.628
Gross margin
€ -7.83213%€ -8.976

Publications in the Belgian Official Journal from KBC Private Partners Life Sciences (PRIVAK)

Frequently asked questions

What is the enterprise number of KBC Private Partners Life Sciences (PRIVAK)?
The enterprise number of KBC Private Partners Life Sciences (PRIVAK) is BE0769268990.
When was KBC Private Partners Life Sciences (PRIVAK) founded?
KBC Private Partners Life Sciences (PRIVAK) was founded on 02-06-2021.
What is the address of KBC Private Partners Life Sciences (PRIVAK)?
The current registered office of KBC Private Partners Life Sciences (PRIVAK) is located at Avenue du Port 2, 1080 Molenbeek-Saint-Jean.
When was the last time KBC Private Partners Life Sciences (PRIVAK) filed their annual financial statements?
The most recent financial statements of KBC Private Partners Life Sciences (PRIVAK) were filed on 04-07-2024. You can view them here.
How many employees does KBC Private Partners Life Sciences (PRIVAK) have?
There are currently no employees working at KBC Private Partners Life Sciences (PRIVAK) or no workforce information is available.
What is the annual turnover of KBC Private Partners Life Sciences (PRIVAK)?
At the time of its most recent financial statements, KBC Private Partners Life Sciences (PRIVAK) did not publish any turnover figures. KBC Private Partners Life Sciences (PRIVAK) reported a gross margin of -€7,831.17.